1,227 followers
"Larger studies are also needed to identify predictors of favorable cardiac outcomes in patients with mild cardiotoxicity who continue trastuzumab treatment." - Dr. Steingart, et al @sloan_kettering https://t.co/rJLjsKe0Ll #jaccco #CardioOnc https://t.co/j